Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/24/23 16:32 | 5/22/23 | CELC | Health | Health | Medical Laboratories | Furcht Leo | MN | D | P.d | 103 | 10.32 | 0 | 10 | 999% | 10 | D | |||||||||||||||
12/13/22 16:47 | 12/9/22 | CELC | Health | Health | Medical Laboratories | Sullivan Brian F. | MN | DOT | CEO | P.d | 1,500 | 5.75 | 0 | 261 | 9 | 3,017 | D | ||||||||||||||
11/23/22 16:10 | 11/22/22 | CELC | Health | Health | Medical Laboratories | Murphy Polly A. | MN | D | P.d | 48 | 9.68 | 0 | 5 | New | 5 | D | |||||||||||||||
9/13/22 17:15 | 9/9/22 | CELC | Health | Health | Medical Laboratories | Nigon Richard | MN | D | P.d | 45 | 8.99 | 0 | 5 | 4 | 116 | D | |||||||||||||||
9/13/18 17:23 | 9/11/18 | CELC | Health | Health | Medical Laboratories | Nigon Richard | MN | D | P.d | 217 | 22.31 | 0 | 10 | 10 | 111 | D | |||||||||||||||
6/4/18 16:27 | 5/31/18 | CELC | Health | Health | Medical Laboratories | Nigon Richard | MN | D | P.d | 190 | 19.04 | 0 | 10 | 11 | 101 | D | |||||||||||||||
11/29/17 17:02 | 11/28/17 | CELC | Health | Health | Medical Laboratories | Nigon Richard | MN | D | P.d | 131 | 17.48 | 0 | 8 | 9 | 91 | D | |||||||||||||||
11/22/17 16:14 | 11/20/17 | CELC | Health | Health | Medical Laboratories | Nigon Richard | MN | D | P.dm | 147 | 17.31 | 0 | 9 | 11 | 83 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |